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 Introduction
During increased electrical brain activity, blood flow
increases, tissue deoxyhemoglobin content decreases,
glucose metabolism increases, and possibly oxygen
metabolism increases. These changes in metabolism
and the hemodynamic consequences are measured
with contemporary brain imaging methods. However,
the measurement of brain activity, be it through the
hemodynamic correlates of increased electrical activ-
ity, increased oxygen consumption, or deoxyglucose
uptake, is unable to depict the fundamentals of brain
activity at the neuroglial level in vivo. Themajormecha-
nism of deactivation of the major excitatory neuro-
transmitter, glutamate, is glial uptake and conversion
to electrophysiologically inactive glutamine, which is
then transported back to the neuron to replenish the
neurotransmitter pool of glutamate, completing the
glutamate–glutamine cycle. It is the purpose of this
article to summarize perspectives on in vivo metabo-
lism in the glial compartment, relative to that in the
neuronal compartment, that have been gained using
an emerging method, namely nuclear magnetic reso-
nance (NMR) spectroscopy. Most measurements are
performed at metabolic steady state, defined as a
condition of metabolic fluxes being constant.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 NMR Spectroscopy of Brain Energy
Metabolism: A Brief Primer
NMR spectroscopy of brain energy metabolism has
focused chiefly on the signals from three NMR-active
nuclei – the ubiquitously used 1H, as well as 31P and
13C. Of the three, 1H and 31P are 100% naturally
abundant, whereas 13C is only 1.1% abundant in
nature. Techniques to establish the quantitative meas-
urement of energy metabolism depend critically on
the specific signal measured from a given nucleus. In
the following discussions, the current state-of-the-art
measurements are given, without elaborating on
methodological considerations in detail.
Proton NMR Spectroscopy
With suppression of the intense signal of water, which
is used for magnetic resonance imaging (MRI), and
elimination of the extracerebral fat signal by adequate
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Encyclopedia of Neuroscienlocalization, amultitude of resonances can be observed
in the in vivo 1H NMR spectrum; these are attributed
to date to more than 20 compounds that can be quan-
titated with typical precision of 10%, amounting to
a neurochemical profile (Figure 1). Quantification is
typically achieved by referencing the metabolite signal
to an internal reference signal of known concentration,
such as water. Metabolic rates are typically either
inferred from measured metabolite concentrations or
from their changes with time.
Phosphorus NMR Spectroscopy
The in vivo signal of the 31P nucleus contains signals
from the three phosphates of ATP – signals from inor-
ganic phosphate and phosphocreatine, as well as
signals attributed to phosphomonoester compounds,
such as phosphoethanolamine and phosphocholine,
and signals attributed to phosphodiesters, such as gly-
cerophosphocholine and ethanolamine. The signals of
ADP and UDP-glucose are in principle observable but
are typically too low to be detected. The chemical shift
of inorganic phosphate reveals intracellular pH, and by
manipulating the magnetization of inorganic phos-
phate, phosphocreatine, or the g-phosphate of ATP
through magnetization transfer, the rates of the reac-
tions of creatine kinase or ATPase can be assessed.
Quantification is typically achieved by referencing
relative to a brain ATP concentration of 3mM.
Carbon-13 NMR Spectroscopy
The sensitivity of 13C NMR spectroscopy can be
improved by administering 13C-labeled precursors,
such as glucose, lactate, b-hydroxybutyrate, or ace-
tate. Further sensitivity improvements are possible by
indirectly detecting the 13C label through vicinal
1H nuclei. As in radiotracer methods, such as posi-
tron emission tomography (PET), the measurement of
label incorporation into metabolic products allows
the determination of metabolic rates using similar
mathematical approaches. Energy metabolism has
been assessed from the measurement of brain glucose,
glycogen, lactate, glutamate, glutamine, and aspar-
tate (Figure 2). Quantification is typically achieved
by performing an external reference measurement.Glycolysis
Glucose Transport
The brain relies on a continuous import of glucose from
the blood across the blood–brain barrier. Glucose
transport rates into the brain are thus indicative of the
maximal sustainable rate of glucose consumption,
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Figure 2 (a) Localized 13C nuclear magnetic resonance spectroscopy of the C1 of glucose and glycogen in rat brain (9.4 T). (b)
Localized 13C nuclear magnetic resonance spectroscopy of the human brain (4 T). Spectra in both panels are shown after [1–13C]glucose
administration. Label incorporation is observed in the predominantly neuronal glutamate and aspartate and the predominantly glial
glutamine, in multiple positions due to label scrambling in the tricarboxcylic acid cycle, and exchange with cytosolic amino acids due to, for
example, the action of the malate–aspartate shuttle.
Membrane metabolism:
13. Phospho-ethanolamine (PE)
14. Phosphocholine (PC)
15. Glycerophosphocholine (GPC)
16. N-acetyl-aspartate (NAA)
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Neurotransmission:
6. Glutamate (Glu)
7. Glutamine (Gln)
8. GABA
9. N-acetyl-asparthyl-glutamate (NAAG)
10. Aspartate (Asp)
11. Glycine (Gly)
12. Serine (ser)
Energy metabolism:
1. Phosphocreatine (PCr)
2. Creatine (Cr)
3. Glucose (Glc)
4. Lactate (Lac)
5. Alanine (Ala)
Antioxidants/osmolytes:
17. Glutathione (GSH)
18. Vitamin C (Asc)
19. Taurine (Tau)
20. Myo-inositol (Ins)
21. Scyllo-inositol (s-Ins)
Figure 1 A neurochemical profile can be derived from the proton nuclear magnetic resonance spectrum of the brain (TE¼2.7ms,
9.4 T). Shown are 21 compounds that can be measured in vivo, grouped according to their major significance. In addition, when present,
acetate and b-hydroxybutyrate can also be measured.
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is important for the derivation of absolute metabolic
fluxes and quantitative positron emission tomography
studies. Steady-state glucose transport kinetics can be
derived from the relationship between brain and
plasma glucose. The former can be directly measured
using NMR spectroscopy.
Brain glucose is distributed in the entire aqueous
phase of the brain The volume in the brain into
which glucose diffuses (i.e., the physical distribution
volume,Vd) is critical in the derivation of glucose trans-
port kinetics. The diffusion behavior of glucose,
measured by diffusion-weighted NMR spectroscopy,
reflects that 80% of the glucose in brain tissue
is intracellular, consistent with a high physical dis-
tribution volume for glucose, Vd¼ 80%, which is
approximately equal to the brain’s water phase. In-
tracellular and extracellular glucose concentrations
are approximately equal, suggesting that transport of
glucose across the cell membranes is fast compar-
ed to the glucose consumption rate. Conversely, the
limiting step for glucose entry into the brain is at
the blood–brain barrier (BBB), comprising the endo-
thelial cells.
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Figure 3 Schematic of glucose (G) transport across the blood–br
reversible Michaelis–Menten kinetic expression for transport (CMRg
Michaelis–Menten kinetics neglect the effect of product concentration
(Tin and Tout) are derived by assuming zero product concentration (i.e
Encyclopedia of Neuroscien
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Glucose content reflects the balance between
transport and consumption The steady-state brain
glucose concentration is a sensitive indicator of the
ability of the BBB to transport glucose relative to
the rate of glucose consumption, Tmax/CMRglc. The
observed linear relationship between plasma and
brain glucose is consistent with the need to take
into account the reversibility of the transport process
(Figure 3). The apparent Km of glucose transport, Kt,
is of the order of 5mM. Decreased electrical activity
and thus decreased energy metabolism result in
increased brain glucose concentrations; yet a sizable
concentration gradient is maintained at isoelectricity,
implicating considerable net glucose uptake and thus
substantial energy metabolism not related to signal-
ing (Figure 4(a)). Increases in luminal glucose trans-
porter (GLUT-1) result in an increase in the maximal
transport capacity of the BBB, the consequence of
which is an accordingly increased brain glucose con-
tent, suggesting that the luminal membrane is the
major rate-determining step for glucose entry into
the brain (Figure 4(b)).
Brain glucose becomes rate limiting for metabolism
when its concentration approaches that of the Km of
the first step in its metabolism, which in the brain isCMRglc
+ CMRglc
Tout = Tmax
Gbrain
(K t + Gplasma)Vd + Gbrain
ain barrier, depicting the steady-state situation and showing the
lc, maximal sustainable rate of glucose consumption). Standard
on reaction velocity (V ), and expressions for the transport rates
., by setting Gbrain ¼ 0 for Tin and Gplasma ¼ 0 for Tout).
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Figure 4 (a) Effect of reduced brain activity on brain glucose
concentration in the rat brain. Reduction of electrical activity
increases brain glucose content substantially, but a considerable
gradient across the blood–brain barrier is maintained (the dashed
line indicates the Gbrain:Gplasma relationship in the absence of a
gradient). (b) Effect of 50% increased blood–brain barrier glucose
transporter GLUT-1 on brain glucose content. GLUT-1 was
increased by inducing chronic hypoglycemia, which led to a sub-
stantial increase in brain glucose content at a constant brain
glucose consumption rate.
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Figure 5 Glucose transport can become rate limiting for metab-
olism, but this is a gradually increasing deficit. The graph shows
the unidirectional glucose influx rate, Tin, relative to the glucose
consumption rate, CMRglc. In this example glucose influx matches
the consumption at Gplasma  2mM. As a result, even at substan-
tial hypoglycemia (e.g., Gplasma ¼ 1.5mM), the glucose supply
(i.e., Tin) accounts for 85% of total glucose requirements.
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Author's personal copymostly phosphorylation by hexokinase. Since the Km
of brain hexokinase is very low (50 mM), brain glu-
cose concentrations that are close to zero indicate
metabolism that is limited by the glucose available
to the brain cell (transport-limited metabolism). The
substantial brain glucose content at euglycemia indi-
cates that brain glucose transport is not rate limit-
ing for metabolism under normal circumstances; the
maximal sustainable rate of glucose consumption is
approximately two to three times above the basal rate
of glucose metabolism. Glucose consumption can,
however, transiently exceed the maximum unidirec-
tional transport into the brain, which may occur in
conditions of extreme metabolic activation, such as
 
 
 
 
 
 
 
 
 
 
 Encyclopedia of Neurosciencduring seizures.While plasma glucose drops, the brain
traverses from excess glucose supply to a condition in
which transport across the BBB supplies just enough
glucose for metabolism, and eventually to a gradually
increasing deficit in glucose supply (Figure 5).
During hypoglycemia, glucose metabolism tends to
decrease and cerebral blood flow (CBF) increases
when the brain glucose concentration approaches
the Km of hexokinase. The mechanism of such blood
flow regulation is different from the neurovascular
coupling in physiological activation, whereby glucose
metabolism and CBF increase concomitantly.
Glial Glycogen – The Only Energy Reserve in Brain
Glycogen, ascribed to the glial compartment, is pres-
ent in concentrations that exceed those of euglycemic
brain glucose by severalfold. It thus comprises by far
the most concentrated endogenous storage of glucose
equivalents in the central nervous system (CNS), and
the presence of glycogen stores is essential for brain
function. Similar to glucose, brain glycogen is rapidly
eliminated postmortem; therefore, its direct biochem-
ical measurement is difficult. Localized 13C NMR
spectroscopy has the unique capability of following
brain glycogen metabolism longitudinally, allowing
measurement of the rate of change of metabolic
rates and concentration changes of glycogen.
Brain glucose can regulate glycogenmetabolism Gly-
cogen metabolism in brain accounts for only a few
percent of total glucose metabolism under resting
conditions. In contrast to transport and metabolism
of bulk brain glucose, glycogen metabolism is strongly
insulin dependent and to a lesser degree its content
 
 
 
 
 e (2009), vol. 4, pp. 773-781 
 
Glial Energy Metabolism: A NMR Spectroscopy Perspective 777 
Author's personal copydepends on the plasma glucose concentration. In deep
anesthesia and hyperglycemia – conditions which are
associated with increased brain glucose content – brain
glycogen levels rise well above the normal concentra-
tion. Together with the apparent stability of glycogen
in the nonstimulated brain at euglycemia or hypergly-
cemia, these data suggest that brain glucose plays an
important regulatory role in cerebral glycogenolysis.
When the intracellular glucose concentration
approaches the Km of hexokinase, glycogen phosphor-
ylase is activated and glycogen synthase is deactivated,
resulting in net glycogenolysis to glucose-6-phosphate
(and some free glucose, due to cleavage of the 1–6 bonds
in glycogen by the debranching enzyme). Glucose-6-
phosphate is eventuallymetabolized to pyruvate, which
can either enter the tricarboxcylic acid (TCA) cycle or
be converted by lactate dehydrogenase to lactate.
Glial lactate can be exported via the action of mono-
carboxylate transporters at the glial and neuronal cell
membranes.
Glycogen stores are neuroprotective By providing
lactate to the extracellular fluid, astrocytes can sus-
tain neuronal energy metabolism of neighboring
neurons in conditions of fuel deprivation, such as
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Postsynaptic neuron
Lac
Lac
ATP AD
ATP, CO2
Lac
Glycogen
Receptor
Glia
Vesicle
ATP, CO2
Glu G
Figure 6 Schematic showing the neuroprotective role of glial glycog
such as lactate (Lac). In glucoprivation, such as hypoglycemia, glu
6-phosphate (Glc-6-P) generation, deactivated glycogen synthase (
glycogen breakdown, through its metabolic pathways (solid thick lines),
probably also neuroprotective through its ability to minimize excitotoxic
cleft in fuel-deprived conditions.
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 hypoglycemia. During glycogenolysis, two ATPs per
glucosyl unit are generated in glycolysis, which can pro-
vide energy to support uptake of synaptic glutamate and
conversion into electrophysiologically inactive gluta-
mine. Astrocytes thus can remove excitotoxic glutamate
from the synaptic cleft in energy-deprived situations,
which may be one mechanism by which glial glycogen
exerts its neuroprotective effect (Figure 6).
Following glycogen depletion, be it induced by
neurotransmitters, by hypoglycemia, by hypoxia, or
by sleep deprivation, brain glycogen increases above
the basal level and beyond in the presence of ample
insulin and glucose, resulting in ‘supercompensation’
similar to that observed for glycogen in noncerebral
tissues. Increased astrocytic glycogen levels reduce
neuronal damage following subsequent fuel depriva-
tion. Brain glycogen metabolism may be a factor
involved in the mechanism of the hypoglycemia
unawareness syndrome observed clinically in patients
with insulin-treated diabetes, probably through the
enhanced neuroprotective effect of increased brain
glycogen.
Glycogen is an important energy reserve Glycogen
serves as an energy reservoir of glucose equivalents.Gln
P
Glc GlcGlc-6-P
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Glc
lu
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en and its ability to nourish neighboring neurons with substrates,
cose phosphorylation impaired, leading to insufficient glucose-
red stars), and activated glycogen phosphorylase. The ensuing
ultimately produces fuel for neighboring neurons. Glial glycogen is
ity by providing energy for removal of glutamate from the synaptic
ce (2009), vol. 4, pp. 773-781 
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Author's personal copyFor example, during aglycemia, when the supply of
glucose to the brain cells is completely abolished, gly-
cogen would sustain total glucose metabolism for
about 20min. However, aglycemia is difficult to
achieve in the living brain, and the reduction of plasma
glucose in reality is gradual in time, resulting in a
gradually increasing glucose supply deficit (Figure 5).
For example, in order to cover a partial supply deficit of
themetabolic rate of glucose of 0.05mmol g1min1 in
the awake human brain (corresponding to a deficit of
14%of a basalmetabolic rate of 0.35 mmol glucose g1
min1), the cerebral content of glycogen of 3.5mmol
glucosyl units g1 can account for this fuel deficit for
more than 1h. The rate of brain glycogen degradation
during hypoglycemia accounts for the majority of the
glucose supply deficit during the hypoglycemic period,
and following extended periods of moderate hypogly-
cemia, substantial glycogen reserves remain. The time
estimated for complete glycogen depletion is 4 h, which
corresponds to the time period that clinically results
in residual neurological symptoms after an episode of
hypoglycemia.
In chronic hypoglycemia, brain glucose content is
elevated (Figure 4(b)), resulting in ambient intracellu-
lar glucose content that appears normal, despite the
prevalent hypoglycemia. In this condition, consistent
with the upregulation of brain glucose content, astro-
cytic 45 kDa GLUT-1 and neuronal GLUT-3 are unal-
tered, as are brain glycogen concentrations.
Glycogen is an important store of glucose equiva-
lents in the brain, having a significant neuroprotective
effect; glycogen metabolism is affected not only by
tissue glucose levels and plasma insulin, but also
by other hormones, neurotransmitters, and second
messengers.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Lactate Metabolism – An Integral Part of Normal
Brain Function
Brain lactate is present at near 1 mmol g1 concentra-
tion under normoxic conditions in vivo, and is con-
tinuously synthesized and broken down. Glucose
and glycogen are the major metabolic precursors for
lactate, which can be exported and serve as fuel for
other cells. A small lactate efflux from the brain is
observed normally. Rapid but small increases in brain
lactate are observed in focal activation, consistent
with a transient uncoupling of oxygen and glucose
metabolism. Similar to that for glucose, lactate dif-
fusion behavior is restricted, indicating that most
tissue lactate is intracellular. Lactate is almost evenly
distributed in the brain’s aqueous phase, owing to the
large transport capacity of the abundant monocar-
boxylate transporters at the neuronal and glial cell
membranes.
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Glutamate Turnover – How Oxygen Metabolism
Is Measured by NMR Spectroscopy
Whenusing a substrate labeled at a suitable position, be
it glucose or other suitable substrates, the measurement
of oxygen metabolism by NMR spectroscopy can be
accomplished by measuring the rate of labeling of glu-
tamate. For simplicity we consider glucose labeled at
the 1 and 6 positions, which labels the C3 of pyruvate
and ultimately the C2 of acetyl-CoA, which condenses
with oxaloacetate to form citrate. In the course of the
metabolic reactions of the TCA cycle, which occur at
a rate denominated as VTCA, label arrives at the C4 of
2-oxoglutarate. Oxoglutarate is exchanged with gluta-
mate through transamination and thus readily labels
mitochondrial glutamate. However, in the brain in
vivo, most of the tissue glutamate is of cytosolic origin,
given the small volume fraction occupied by mitochon-
dria. Therefore, when label incorporation into gluta-
mate is observed, it reflects a signal ascribed mainly to
the cytosol (Figure 7(a)). The label scrambling, how-
ever, occurs in the mitochondria. Carbon-13 label is
transferred to the cytosolic glutamate by label exchange
across the inner mitochondrial membrane. Processes
such as the malate–aspartate shuttle (Figure 7(b)),
which transfer reducing equivalents from the cytosol
to the mitochondrion, play a key role in label exchange
across themitochondrialmembrane.Therefore, the rate
of labeling of glutamate is both a function of the TCA
cycle rate (VTCA) as well as of isotope exchange across
the inner mitochondrial membrane (Vx).
When considering the further fate of label in the C4
of glutamate (and conversely theC4of 2-oxoglutarate),
the investigational power of NMR spectroscopy can
be demonstrated. The label at C4 of 2-oxoglutarate
proceeds along the TCA cycle to scramble equally
between theC2andC3of succinate (a symmetricmole-
cule), which ultimately leads to a symmetric labeling
of the C2 and C3 of 2-oxoglutarate and thus by the
same exchange mechanism (Vx in Figure 7(a)) the C2
and C3 of glutamate. Hence, as a result of metabolic
reactions ascribed to the TCA cycle, label from a singly
labeled acetyl-CoA molecule results in labeling of
glutamate in three positions in two turns of the TCA
cycle. Whereas the labeling of the C4 of glutamate
takes up a simple analytical form of an exponential
function, the rate of which is the geometric average of
VTCA and Vx divided by the glutamate pool size, the
labeling of the C2 and C3 of glutamate is more com-
plex. Briefly, at the C3 position, glutamate receives
label not only from acetyl-CoA, but since some of the
label escapes the oxoglutarate pool into glutamate
(with a probability determined by the relative rate of
VTCA and Vx), its C4 position increasingly serves as
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Figure 7 The flow of label from glucose to glutamate: (a) illustration of the flow of label from acetyl-CoA to glutamate; (b) the metabolic
reactions involved in the malate–aspartate shuttle. The malate–aspartate (Asp) shuttle allows the cell to combust glucose oxidatively, by
transferring the reducing equivalent generated per pyruvate (Pyr) molecule oxidized to the mitochondrion. This shuttle is critical in
permitting respiring neural cells to metabolize glucose. When pyruvate is the sole fuel for the tricarboxcylic acid (TCA) cycle, the TCA
cycle rate VTCA¼VPDH (PDH, pyruvate dehydrogenase; Vx, isotope exchange across the inner mitochondrial membrane; OG, oxoglu-
tarate; OAA, oxaloacetic acid).
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Author's personal copylabel substrate for the C3. Since the rate of labeling of
Glu4 is delayed compared to that of acetyl-CoA, due
to the time required to completely label the gluta-
mate pool, the labeling of Glu3 is an increasingly
concave function when increasing transmitochon-
drial exchange rate Vx, which thus can be assessed,
allowing important insights into the regulation of
oxidative metabolism and mitochondrial integrity
 
 
 Encyclopedia of Neuroscienin vivo. The labeling of glutamate by itself does not
permit to study compartmentalization between astro-
cytes and neurons, however, as glutamate is ubiqui-
tously present in many cells, including astrocytes.
The Glutamate–Glutamine Cycle
Glial-specific tracers Acetate and glucose do not
share the same product-precursor relationship.
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taken up by astrocytes, and hence labeled acetate can
be used to ‘trace’ glial metabolism, whether it is by
using radiotracers, as in 14C autoradiography or
11C (using PET), or by using [13C]acetate in conjunc-
tion with NMR spectroscopy. The advantage of using
acetate as a tracer lies in its exclusive uptake into the
astrocytes, and thus from the turnover of glutamate,
astrocytic TCA cycle flux can be assessed.
Labeled acetate will thus label glial glutamate
much in the same manner as discussed previously;
however, the action of glutamine synthetase and the
diffusion of glutamine from the astrocyte into the
presynaptic terminal result in label being scrambled
from glutamine to neuronal glutamate, where it is
being diluted with unlabeled carbon derived from
the neuronal TCA cycle; this leads to a lower isotopic
enrichment of tissue glutamate, compared to tissue glu-
tamine (resulting in an anomalous product-precursor
relationship). In general, glutamate and glutamine are
not labeled to an equal extent, reflecting the substantial
activity of the glial TCA cycle (see later).
When electrical activity ceases (isoelectricity) the
glutamate–glutamine cycle activity is close to zero,
but substantial energy is still expended, powering
ion gradients, among others. This results in a substan-
tial glucose concentration gradient at isoelectricity
and active oxygen consumption (Figure 4(a)). With
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Figure 8 Schematic depiction of the metabolic relationship between
nuclear magnetic resonance spectroscopy in vivo. Deactivation of ne
conversion to glutamine, which at least in part diffuses back into the
activated glutaminase, completing the glutamate–glutamine cycle (thi
Encyclopedia of Neuroscienc
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 increasing electrical activity, the rate of glutamine
synthesis increases but the glutamate–glutamine
cycle does not operate stoichiometrically.
Glutamine Synthetase and Pyruvate Carboxylase
The synthesis of glutamine is catalyzed by glutamine
synthetase (EC 6.3.1.2), which is attributed to the
glial compartment (Figure 8). Hence the in vivo obser-
vation of glutamine labeling by 13C NMR is a direct
manifestation of glial metabolism. In principle, the
simultaneous observation of labeling of glutamate,
mainly ascribed to the neuronal compartment, and glu-
tamine, a glial reaction, would thus follow the path
of acetyl-CoA! glutamate! glutamine! glutamate,
and thus would represent a direct manifestation of the
glutamate–glutamine cycle, which is the dominant
mechanism of glutamate neurotransmission. How-
ever, additional labeling of glutamine occurs via the
glial TCA cycle, as astrocytes contain mitochondria
and thus the necessary enzymatic predisposition for
oxidative generation of energy (e.g., a high cytochrome
oxidase content).
The presence of significant glial oxidative metabo-
lism results in incorporation into glutamine label that
does not match that of glutamate. Reactions asso-
ciated with CO2 fixation, such as the major anaplero-
tic enzyme, pyruvate carboxylase (EC 6.4.1.1), have
been localized to astrocytes. De novo synthesis ofspartate
Glucose
Glutamine
TCA
Na+ Ca2+
Glutamate
Capillary
Neuron
Neuron
neurons and glia. The compounds in red are those measured by
urotransmitter glutamate is primarily by uptake into the glia and
presynaptic terminal, to be converted to glutamate by phosphate-
ck arrows; TCA, tricarboxcylic acid).
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Author's personal copyamino acids is thus a unique capability of the glial
compartment, given that transamination which
occurs in both astrocytes and neurons by itself cannot
provide a net increase in tissue TCA cycle intermedi-
ate and hence amino acid concentration. In the reac-
tion catalyzed by pyruvate carboxylase, pyruvate is
combined with CO2 to form oxaloacetate (OAA). As
previously, we consider glucose labeled at the 1 and 6
positions as the precursor molecule, which results in
label incorporation in the C3 of oxaloacetate from
the C3 of pyruvate, which in turn labels the C2 of
oxoglutarate, and thus the C2 of glutamate. As a
result, the C2 of glutamate is labeled to a larger extent
than is the C3. By comparing the labeling of gluta-
mate in C2 and C3, the quantitative presence of ana-
plerotic reactions can be estimated in vivo by NMR,
although some equilibrating flux back to fumarate
may obscure the true extent of CO2 fixation present.
Anaplerotic reactions are a substantial metabolic
activity in the brain, amounting to approximately
one-third of glutamine synthesis, and are linked to
brain activity. Anaplerotic reactions are decreased in
metabolically depressed states, resulting in reduced
glutamine synthesis and lowered brain glutamate and
glutamine concentrations in hibernation, for example.
Net synthesis of glutamine from glucose produces
approximately ten ATPs per glutamine molecule, from
the generation of several NADH molecules in the pro-
cess, and thus is energetically favorable.
Summary
At rest, most of the energy requirements in the brain
are matched by oxidative metabolism of glucose.
Oxygen metabolism is uniquely compartmentalized
between neurons and glia, the latter comprising about
25% of the energy metabolism. The consumption of
acetate and fixation of CO2 in glutamine are oxygen-
dependent glial reactions. At least two-thirds of the
ATP generated in astrocytes is by oxidative processes.
Astrocytes thus can, in a unique way, buffer metabolic
demand of the tripartite synapse. Glia exhibit a large
capacity to phosphorylate glucose and can store it in
the form of glycogen, the glucose equivalents of which
can be exported in the form of lactate to neurons,
providing neuroprotection. Astrocytes have a sub-
stantial anaplerotic activity, as de novo synthesis of
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 glutamine by itself is an energetically favorable process.
Glia therefore adapt the fuel demands to the specific
requirements encountered in activation, hypoglycemia,
and deactivation, nurturing surrounding neurons with
substrates, while at the same time eliminating neuro-
transmitter glutamate from the synaptic cleft.
See also: Activity-Dependent Metabolism in Glia and
Neurons; Glial Energy Metabolism: Overview; Glial
Glycogen Metabolism; Glial Glutamate and GABA
Metabolism; Glial Plasticity and Neuroendocrine
Regulation; Glutamatergic and Gabaergic Systems;
Magnetic Resonance Spectroscopy; Perfusion MRI.Further Reading
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